Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective and Observational Study of Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029. Prospective Study EPOOzo-2.

NCT07325851 is registered in ClinicalTrials.gov with Bernardino Clavo, MD, PhD as lead sponsor.

NCT NCT07325851
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07325851 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective and Observational Study of Patients Referred to the Chronic Pain Unit for Palliative Treatment With Ozone Therapy Between 2026 and 2029. Prospective Study EPOOzo-2.
Lead sponsor
Bernardino Clavo, MD, PhD
Phase
Observational
Overall status
Recruiting
Start date
January 14, 2026
Completion date
June 30, 2030
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemotherapy-induced peripheral neuropathy, chronic pain, delayed wound healing, radiation toxicity, refractory symptoms